Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity (Q42798992)

7 November 2017

title

Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity (English)

1 reference

7 November 2017

1 reference

Yongqing Liu

1

1 reference

7 November 2017

Weidong Zhang

2

1 reference

7 November 2017

Tim Chan

3

1 reference

7 November 2017

Anurag Saxena

4

1 reference

7 November 2017

Jim Xiang

5

1 reference

7 November 2017

publication date

1 August 2002

1 reference

7 November 2017

1 reference

7 November 2017

volume

26

1 reference

7 November 2017

issue

8

1 reference

7 November 2017

page(s)

757-763

1 reference

The transporters associated with antigen presentation

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Histamine induces CD86 expression and chemokine production by human immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Regression of engineered tumor cells secreting cytokines is related to a shift in host cytokine profile from type 2 to type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Dendritic cells: antigen presentation, accessory function and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Origin, maturation and antigen presenting function of dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Cytokines and their effects on maturation, differentiation and migration of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900002-4

7 January 2021

10.1016/S0145-2126(02)00002-4

Identifiers

DOI

1 reference

release_rknvwhdbbbhc3c3zyy3b32oksa

7 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rknvwhdbbbhc3c3zyy3b32oksa

24 November 2022

mapped directly with Wikidata item

1 reference